Saltar al contenido
Merck

Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.

Molecular pharmacology (2012-12-13)
Maria H Jäntti, Jaana Putula, Pauli M Turunen, Johnny Näsman, Sami Reijonen, Christer Lindqvist, Jyrki P Kukkonen
RESUMEN

It has been proposed that OX(1) orexin receptors and CB(1) cannabinoid receptors can form heteromeric complexes, which affect the trafficking of OX(1) receptors and potentiate OX(1) receptor signaling to extracellular signal-regulated kinase (ERK). We have recently shown that OX(1) receptor activity releases high levels of the endocannabinoid 2-arachidonoyl glycerol (2-AG), suggesting an alternative route for OX(1)-CB(1) receptor interaction in signaling, for instance, in retrograde synaptic transmission. In the current study, we set out to investigate this possibility utilizing recombinant Chinese hamster ovary K1 cells. 2-AG released from OX(1) receptor-expressing cells acted as a potent paracrine messenger stimulating ERK activity in neighboring CB(1) receptor-expressing cells. When OX(1) and CB(1) receptors were expressed in the same cells, OX(1) stimulation-induced ERK phosphorylation and activity were strongly potentiated. The potentiation but not the OX(1) response as such was fully abolished by specific inhibition of CB(1) receptors or the enzyme responsible for 2-AG generation, diacylglycerol lipase (DAGL). Although the results do not exclude the previously proposed OX(1)-CB(1) heteromerization, they nevertheless unequivocally identify DAGL-dependent 2-AG generation as the pivotal determinant of the OX(1)-CB(1) synergism and thus suggest a functional rather than a molecular interaction of OX(1) and CB(1) receptors.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Lipoprotein Lipase from Pseudomonas sp., lyophilized, powder, ≥1200 U/mg
Sigma-Aldrich
Lipoprotein Lipase from Burkholderia sp., lyophilized powder, ≥50,000 units/mg solid
Sigma-Aldrich
Lipoprotein Lipase from bovine milk, ammonium sulfate suspension, ≥2,000 units/mg protein (BCA)